KIRLOSELEC

Envair Electrodyne Share Price

 

Stock touched 52W low

 

Start SIP in KIRLOSELEC

Start SIP

Performance

  • Low
  • ₹66
  • High
  • ₹70
  • 52 Week Low
  • ₹66
  • 52 Week High
  • ₹140
  • Open Price₹68
  • Previous Close₹68
  • Volume1,359
  • 50 DMA₹73.88
  • 100 DMA₹77.99
  • 200 DMA₹88.83

Investment Returns

  • Over 1 Month + 1.5%
  • Over 3 Month 0%
  • Over 6 Month -17.87%
  • Over 1 Year -47.38%

Smart Investing Starts Here Start SIP with Envair Electrodyne for Steady Growth!

Invest Now

Envair Electrodyne Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -51
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 33
  • P/B Ratio
  • 3.8
  • Average True Range
  • 3.23
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.57
  • RSI
  • 47.26
  • MFI
  • 29.74

Envair Electrodyne Financials

Envair Electrodyne Technicals

EMA & SMA

Current Price
₹70.25
+ 2.21 (3.25%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹70.84
  • 50 Day
  • ₹73.88
  • 100 Day
  • ₹77.99
  • 200 Day
  • ₹88.83

Resistance and Support

68.84 Pivot Speed
  • R3 75.93
  • R2 73.10
  • R1 71.67
  • S1 67.41
  • S2 64.58
  • S3 63.15

Envair Electrodyne Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-11 Quarterly Results
2025-05-26 Audited Results
2025-02-10 Quarterly Results
2024-11-12 Quarterly Results

Envair Electrodyne F&O

Envair Electrodyne Shareholding Pattern

No data available.

Envair Electrodyne FAQs

Envair Electrodyne share price is ₹70 As on 10 January, 2026 | 07:03

The Market Cap of Envair Electrodyne is ₹32.6 Cr As on 10 January, 2026 | 07:03

The P/E ratio of Envair Electrodyne is -51 As on 10 January, 2026 | 07:03

The PB ratio of Envair Electrodyne is 3.8 As on 10 January, 2026 | 07:03

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23